HCW Biologics withdraws equity plan proposal from proxy; reschedules special meeting

HCW Biologics Inc.

Board withdrew Proposal No.2 (amended performance-based equity plan) after stockholder feedback.
Special Meeting of Stockholders date and record date changed via Amendment No.1 to PRE 14A.
Amendment filed Sept 9, 2026; no other substantive changes to original proxy.
Original PRE 14A filed Sept 8, 2026; amendment restates it in full.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.